Insider · CIK 0001864158

Campbell David Alan

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001864158

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-31	JANXJanux Therapeutics, Inc.G Gift	Director, President and CEO	GGift	−124K sh	—	—	264,742
2026-07-08	JANXJanux Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+7,000 sh	$4.21	+$29.5K	388,582
2026-07-08	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−7,000 sh	—	—	697,550
2026-01-02	JANXJanux Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−8,072 sh	$13.73	−$111K	284,982
2026-01-02	JANXJanux Therapeutics, Inc.A Award	Director, President and CEO	AAward	+96.6K sh	—	—	381,582
2026-01-02	JANXJanux Therapeutics, Inc. · Stock option (right to buy)A Award	Director, President and CEO	AAward	+338K sh	—	—	338,100
2025-01-07	JANXJanux Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−5,000 sh	$60.00	−$300K	293,054
2025-01-02	JANXJanux Therapeutics, Inc.A Award	Director, President and CEO	AAward	+81K sh	—	—	298,054
2025-01-02	JANXJanux Therapeutics, Inc. · Stock option (right to buy)A Award	Director, President and CEO	AAward	+284K sh	—	—	283,500
2024-12-24	JANXJanux Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−25K sh	$56.19	−$1.4M	217,054
2024-12-03	JANXJanux Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−15K sh	$67.00	−$1.01M	242,054
2024-11-25	JANXJanux Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−18.3K sh	$51.43	−$940K	263,773
2024-11-25	JANXJanux Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−6,719 sh	$52.04	−$350K	257,054
2024-10-28	JANXJanux Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−13.9K sh	$53.22	−$740K	293,157
2024-10-28	JANXJanux Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−11.1K sh	$53.94	−$599K	282,054
2024-09-27	JANXJanux Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−19K sh	$46.09	−$874K	313,097
2024-09-27	JANXJanux Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−5,248 sh	$46.85	−$246K	307,849
2024-09-27	JANXJanux Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−795 sh	$47.84	−$38K	307,054
2024-01-02	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+357K sh	—	—	356,500
2023-01-03	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+310K sh	—	—	310,000
2022-01-03	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+354K sh	—	—	354,250

Recent filings

Accepted (ET)
Jul 314
Campbell David Alan0001864158-26-000006
SEC(opens sec.gov)
Jul 104
Campbell David Alan0001864158-26-000004
SEC(opens sec.gov)
Jan 24
Campbell David Alan0001864158-26-000002
SEC(opens sec.gov)
Jan 84
Campbell David Alan0001415889-25-001165
SEC(opens sec.gov)
Jan 34
Campbell David Alan0001415889-25-000675
SEC(opens sec.gov)
Dec 274
Campbell David Alan0001415889-24-030211
SEC(opens sec.gov)
Dec 34
Campbell David Alan0001415889-24-028203
SEC(opens sec.gov)
Nov 274
Campbell David Alan0001415889-24-027905
SEC(opens sec.gov)
Oct 304
Campbell David Alan0001415889-24-025792
SEC(opens sec.gov)
Sep 274
Campbell David Alan0001415889-24-024074
SEC(opens sec.gov)
Jan 34
Campbell David Alan0001209191-24-000431
SEC(opens sec.gov)
Jan 54
Campbell David Alan0001209191-23-001867
SEC(opens sec.gov)

Companies

Janux Therapeutics, Inc.Director, President and CEOJANX

Address

C/O JANUX THERAPEUTICS, INC. 10955 VISTA SORRENTO PARKWAY, SUITE 200

SAN DIEGO, CA, 92130